IDL Diagnostics AB (publ) (STO:IDLDX)
Sweden · Delayed Price · Currency is SEK 0.4140
+0.0160 (4.02%)
Aug 27, 2026, 4:40 PM CET
IDL Diagnostics AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 58.95 | 53.11 | 57.44 | 43.04 | 36.99 | 12 |
| 58.95 | 53.11 | 57.44 | 43.04 | 36.99 | 12 | |
Revenue Growth | 7.55% | -7.54% | 33.45% | 16.37% | 208.32% | 14180.95% |
Cost of Revenue | 24.44 | 25.38 | 25.88 | 45.14 | 39.09 | 17.04 |
Gross Profit | 34.51 | 27.73 | 31.56 | -2.1 | -2.11 | -5.05 |
Selling, General & Admin | 24.89 | 24.87 | 23.93 | 33.07 | 35.82 | 26 |
Research & Development | 13.76 | 13.59 | 12.9 | 25.24 | 24.43 | 19.83 |
Other Operating Expenses | -0.01 | -0.01 | -0.04 | -0.42 | -2.23 | -0.06 |
Operating Expenses | 38.64 | 38.45 | 36.79 | 57.9 | 58.02 | 45.77 |
Operating Income | -4.13 | -10.72 | -5.23 | -60 | -60.12 | -50.82 |
Interest Expense | -0.42 | -0.45 | -0.5 | -0.01 | -0.01 | - |
Interest & Investment Income | 0.33 | 0.29 | 0.98 | 0.5 | 0.01 | - |
Currency Exchange Gain (Loss) | -0.21 | -1.3 | 1.4 | 0.21 | 0.82 | 0.24 |
Other Non Operating Income (Expenses) | 0 | 0 | 0 | - | -0 | - |
EBT Excluding Unusual Items | -4.43 | -12.17 | -3.34 | -59.3 | -59.3 | -50.57 |
Gain (Loss) on Sale of Assets | 0.02 | 0.02 | - | - | - | - |
Pretax Income | -4.41 | -12.15 | -3.34 | -59.3 | -59.3 | -50.57 |
Earnings From Continuing Operations | -4.41 | -12.15 | -3.34 | -59.3 | -59.3 | -50.57 |
Minority Interest in Earnings | - | - | - | - | 0.33 | 0.55 |
Net Income | -4.41 | -12.15 | -3.34 | -59.3 | -58.97 | -50.03 |
Net Income to Common | -4.41 | -12.15 | -3.34 | -59.3 | -58.97 | -50.03 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 230 | 230 | 230 | 230 | 215 | 94 |
Shares Outstanding (Diluted) | 230 | 235 | 235 | 230 | 215 | 94 |
Shares Change | - | - | 2.17% | 6.97% | 128.22% | 28.18% |
EPS (Basic) | -0.02 | -0.05 | -0.01 | -0.26 | -0.27 | -0.53 |
EPS (Diluted) | -0.02 | -0.05 | -0.01 | -0.26 | -0.27 | -0.53 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -5.68 | -8.27 | -2.5 | -13.93 | -16.72 | -28.21 |
Free Cash Flow Per Share | -0.03 | -0.04 | -0.01 | -0.06 | -0.08 | -0.30 |
Gross Margin | 58.54% | 52.22% | 54.95% | -4.88% | -5.69% | -42.06% |
Operating Margin | -7.01% | -20.18% | -9.10% | -139.40% | -162.55% | -423.61% |
Profit Margin | -7.49% | -22.88% | -5.81% | -137.78% | -159.45% | -417.01% |
Free Cash Flow Margin | -9.63% | -15.57% | -4.35% | -32.38% | -45.20% | -235.13% |
EBITDA | -2.97 | -9.62 | -3.93 | -14.46 | -12.94 | -30.51 |
EBITDA Margin | -5.03% | -18.11% | -6.84% | -33.60% | -34.99% | -254.30% |
D&A For EBITDA | 1.17 | 1.1 | 1.3 | 45.54 | 47.18 | 20.31 |
EBIT | -4.13 | -10.72 | -5.23 | -60 | -60.12 | -50.82 |
EBIT Margin | -7.01% | -20.18% | -9.10% | -139.40% | -162.55% | - |